BC is a heterogenous disease that can be subdivided into different subtypes based on the expression of hormonal and other receptors, such as the estrogen receptor (ER), the progesterone receptor (PR) and the human epidermal growth factor receptor 2 (HER2) (6). This evidence concerns the gene ERBB2 and breast cancer.